EPIRUS Biopharmaceuticals (EPRSQ) Short Interest Ratio & Short Volume → Gold Mania (From Stansberry Research) (Ad) Free EPRSQ Stock Alerts Add Compare Share Share Short InterestStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest EPIRUS Biopharmaceuticals Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Today's Trading Volume0 sharesAverage Trading Volume3 sharesToday's Volume Vs. Average0% Short Selling EPIRUS Biopharmaceuticals ? Sign up to receive the latest short interest report for EPIRUS Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEPRSQ Short Interest Over TimeEPRSQ Days to Cover Over TimeEPRSQ Percentage of Float Shorted Over Time Ad AltimetryStock-Picking AI Predicts #1 Stock of 2024Since the start of the year, the top 10 investment funds in the world – including Vanguard, Blackrock, Fidelity and JP Morgan – have made nearly $1 trillion in profits on these 7 stocks.Click here to learn what's coming (and how to prepare). EPIRUS Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024100 shares $0.00 No ChangeN/A0 $0.00 3/31/2024100 shares $0.00 No ChangeN/A0 $0.00 3/15/2024100 shares $0.00 No ChangeN/A0 $0.00 2/29/2024100 shares $0.00 No ChangeN/A0 $0.00 2/15/2024100 shares $0.00 No ChangeN/A1 $0.00 1/15/2024100 shares $0.00 No ChangeN/A0.3 $0.00 Get the Latest News and Ratings for EPRSQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for EPIRUS Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023100 shares $0.00 No ChangeN/A0.1 $0.00 12/15/2023100 shares $0.00 No ChangeN/A0 $0.00 11/30/2023100 shares $0.00 No ChangeN/A0 $0.00 11/15/2023100 shares $0.00 No ChangeN/A1 $0.00 10/31/2023100 shares $0.00 No ChangeN/A0 $0.00 10/15/2023100 shares $0.00 No ChangeN/A1 $0.00 9/30/2023100 shares $0.00 No ChangeN/A1 $0.00 9/15/2023100 shares $0.00 No ChangeN/A0 $0.00 8/31/2023100 shares $0.00 No ChangeN/A0 $0.00 8/15/2023100 shares $0.00 No ChangeN/A0 $0.00 7/31/2023100 shares $0.00 No ChangeN/A0 $0.00 7/15/2023100 shares $0.00 No ChangeN/A0 $0.00 6/30/2023100 shares $0.00 No ChangeN/A1 $0.00 6/15/2023100 shares $0.00 No ChangeN/A0 $0.00 5/31/2023100 shares $0.00 No ChangeN/A0 $0.00 5/15/2023100 shares $0.00 No ChangeN/A1 $0.00 4/30/2023100 shares $0.00 No ChangeN/A1 $0.00 4/15/2023100 shares $0.00 No ChangeN/A1 $0.00 3/31/2023100 shares $0.00 No ChangeN/A1 $0.00 3/15/2023100 shares $0.00 No ChangeN/A1 $0.00 2/28/2023100 shares $0.00 No ChangeN/A1 $0.00 2/15/2023100 shares $0.00 No ChangeN/A1 $0.00 1/31/2023100 shares $0.00 No ChangeN/A0 $0.00 1/15/2023100 shares $0.00 No ChangeN/A1 $0.00 12/30/2022100 shares $0.00 No ChangeN/A1 $0.00 12/15/2022100 shares $0.00 No ChangeN/A0 $0.00 11/30/2022100 shares $0.00 No ChangeN/A0 $0.00 11/15/2022100 shares $0.00 No ChangeN/A1 $0.00 10/31/2022100 shares $0.00 No ChangeN/A0.5 $0.00 10/15/2022100 shares $0.00 No ChangeN/A0.3 $0.00 9/30/2022100 shares $0.00 No ChangeN/A1 $0.00 9/15/2022100 shares $0.00 No ChangeN/A0 $0.00 8/31/2022100 shares $0.00 No ChangeN/A1 $0.00 8/15/2022100 shares $0.00 No ChangeN/A0 $0.00Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details EPRSQ Short Interest - Frequently Asked Questions What is EPIRUS Biopharmaceuticals' current short interest? Short interest is the volume of EPIRUS Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 100 shares of EPRSQ short. Learn More on EPIRUS Biopharmaceuticals' current short interest. How does EPIRUS Biopharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to EPIRUS Biopharmaceuticals: Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), IMV Inc. (1.31%), LAVA Therapeutics (1.37%), Mainz Biomed (2.30%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short EPIRUS Biopharmaceuticals stock? Short selling EPRSQ is an investing strategy that aims to generate trading profit from EPIRUS Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against EPIRUS Biopharmaceuticals? A short squeeze for EPIRUS Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EPRSQ, which in turn drives the price of the stock up even further. How often is EPIRUS Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPRSQ, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NEVPF Short Interest AFFY Short Interest ABMC Short Interest ANTH Short Interest BAYRY Short Interest CNTX Short Interest IMUC Short Interest GNMSF Short Interest GBIM Short Interest GRFS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EPRSQ) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsUrgent Nvidia WarningAltimetry